These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9088554)

  • 21. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of animals in the development and control of viral vaccines.
    Minor PD
    Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical focus assay for potency determination of measles-mumps-rubella trivalent vaccine.
    Fukuda A; Hishiyama M; Umino Y; Sugiura A
    J Virol Methods; 1987 Mar; 15(4):279-84. PubMed ID: 2438297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined administration of measles, mumps, rubella, and trivalent oral poliovirus vaccines.
    Krugman RD; Witte JJ; Parkman PD; Herrmann KL; Meyer HM; Wende RD; Meyer BC; Dungca R
    Public Health Rep; 1977; 92(3):220-2. PubMed ID: 866558
    [No Abstract]   [Full Text] [Related]  

  • 26. No confirmation of pestivirus RNA in human virus vaccines.
    Vilcek S; Paton DJ; Minor P; Bentley M
    J Clin Microbiol; 1999 May; 37(5):1653. PubMed ID: 10328688
    [No Abstract]   [Full Text] [Related]  

  • 27. Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer.
    McAleer WJ; Markus HZ; McLean AA; Buynak EB; Hilleman MR
    J Biol Stand; 1980; 8(4):281-7. PubMed ID: 7009615
    [No Abstract]   [Full Text] [Related]  

  • 28. [Simple detection of the contamination in animal cell cultures].
    Harasawa R; Mizusawa H; Takeuchi M
    Tanpakushitsu Kakusan Koso; 1995 Nov; 40(15):2361-8. PubMed ID: 8532895
    [No Abstract]   [Full Text] [Related]  

  • 29. [The value of the first and second measles-mumps-rubella immunization according to the STIKO (Permanent Immunization Committee) recommendations. Interview by Marianne E Tippmann].
    Stück B
    Kinderkrankenschwester; 2000 Jan; 19(1):25-7. PubMed ID: 10734856
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of a highly sensitive PCR/DNA chip method to detect mycoplasmas in a veterinary modified live vaccine.
    Mbelo S; Gay V; Blanchard S; Abachin E; Falque S; Lechenet J; Poulet H; de Saint-Vis B
    Biologicals; 2018 Jul; 54():22-27. PubMed ID: 29753589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies.
    Makino S; Sasaki K; Nakayama T; Oka S; Urano T; Kimura M; Kawana R; Yamamura AM
    Am J Dis Child; 1990 Aug; 144(8):905-10. PubMed ID: 2198807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants.
    Dunlop JM; RaiChoudhury K; Roberts JS; Bryett KA
    Public Health; 1989 Sep; 103(5):331-5. PubMed ID: 2798746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impotency of live-virus vaccines as a result of improper handling in clinical practice.
    Krugman RD; Meyer BC; Enterline JC; Parkman PD; Witte JJ; Meyer HM
    J Pediatr; 1974 Oct; 85(4):512-4. PubMed ID: 4443859
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum.
    Bolin SR; Ridpath JF
    J Vet Diagn Invest; 1998 Apr; 10(2):135-9. PubMed ID: 9576339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
    Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG
    Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine production in human diploid cell strains.
    Plotkin SA
    Am J Epidemiol; 1971 Oct; 94(4):303-6. PubMed ID: 4329326
    [No Abstract]   [Full Text] [Related]  

  • 38. [Viral vaccines--current status and developmental trends].
    Starke G
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):495-503. PubMed ID: 4940028
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What is the present status of the common virus vaccines?].
    Regnard J
    Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.